Newsroom | 9092 results

NEW YORK--(BUSINESS WIRE)--ACCESS GPO today announced a preferred, multi-year agreement with Medtronic to support availability of the Affera™ Mapping and Ablation System with Sphere-9™ Catheter in ambulatory surgery centers (ASCs) across the United States. The agreement is designed to help physician-led ASCs gain earlier access to next-generation technology for treatment of cardiac arrhythmias in the ASC setting. Pulsed field ablation (PFA) is emerging as one of the most important advances in t...

BOSTON--(BUSINESS WIRE)--Form Health, the national leader in science-based obesity and cardiometabolic care, today announced it has joined Eli Lilly and Company's new Lilly Employer Connect platform, helping employers expand access to obesity management medications through flexible benefit design and more predictable pricing. Through Lilly Employer Connect, employers can work with independent program administrators like Form to design programs that expand access to obesity treatment while addre...

PITTSBURGH--(BUSINESS WIRE)--RQM+, una CRO leader nel settore MedTech che offre servizi di consulenza normativa, sperimentazione clinica, laboratorio e rimborso, ha annunciato oggi il lancio di SMART Solutions, un modello di collaborazione per il ciclo di vita progettato per aiutare le aziende di dispositivi medici e diagnostici a gestire la crescente complessità normativa e di sviluppo. SMART Solutions introduce uno schema operativo su base strategica che unisce competenze in ambito normativo,...

PITTSBURGH--(BUSINESS WIRE)--RQM+ ist eine führende MedTech CRO, die Beratung in regulatorischen Angelegenheiten und Dienste für klinische Versuche, Labor und Erstattung bietet. Das Unternehmen gab heute die Einführung von SMART Solutions bekannt, einem Life Cycle Partnerschaftsmodell, das Unternehmen für medizinische Geräte und Diagnostik dabei hilft, mit zunehmend komplexen Anforderungen bei Vorschriften und Entwicklung fertig zu werden. SMART Solutions führt ein strategisch fundiertes Rahmen...

PITTSBURGH--(BUSINESS WIRE)--RQM+, une CRO MedTech de premier plan offrant des services de conseil réglementaire, d'essais cliniques, de laboratoire et de remboursement, a annoncé aujourd'hui le lancement de SMART Solutions, un modèle de partenariat pour le cycle de vie qui permet aux entreprises de dispositifs médicaux et de diagnostic de gérer la complexité croissante des réglementations et du développement. SMART Solutions présente un cadre opérationnel axé sur la stratégie qui unifie les ex...

PITTSBURGH--(BUSINESS WIRE)--RQM+, een toonaangevende CRO voor MedTech die diensten aanbiedt op het gebied van regelgevingsadvies, klinische studies, laboratoriumonderzoek en vergoedingen, heeft vandaag de lancering aangekondigd van SMART Solutions, een samenwerkingsmodel voor de gehele productlevenscyclus. Dit model is ontworpen om bedrijven in de medische hulpmiddelen- en diagnostieksector te helpen bij het beheersen van de toenemende complexiteit van regelgeving en ontwikkeling. SMART Soluti...

PITTSBURGH--(BUSINESS WIRE)--RQM+, una organización de investigación por contrato (CRO) líder en tecnología médica que presta servicios de consultoría normativa, ensayos clínicos, laboratorio y reembolsos, ha anunciado hoy el lanzamiento de SMART Solutions, un modelo de colaboración para el todo el ciclo del producto, diseñado para ayudar a las empresas especializadas en dispositivos médicos y diagnósticos a gestionar la complejidad creciente en materia de normativa y desarrollo. SMART Solution...

SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Reports Fourth Quarter and Full Year 2025 Results...

PITTSBURGH--(BUSINESS WIRE)--RQM+, a leading MedTech CRO offering regulatory consulting, clinical trial, laboratory, and reimbursement services, today announced the launch of SMART Solutions, a life cycle partnership model designed to help medical device and diagnostics companies manage growing regulatory and development complexity. SMART Solutions introduces a strategy-led operating framework that unifies regulatory, quality, clinical, reimbursement, and laboratory expertise to support MedTech...

SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced that the New England Journal of Medicine has published full results of its phase 3 TETON-2 study evaluating the use of nebulized Tyvaso for the treatment of IPF. The publication is available online at NEJM.org. The study met its primary efficacy endpoint, with nebulized Tyvaso demonstrating statistically significant improvement in abso...